GlobeNewswire

Annual General Meeting of Infant Bacterial Therapeutics

Share

At the Annual General Meeting of Infant Bacterial Therapeutics AB (publ) on May 4, 2021, among other things, the following was resolved:

  • adoption of the annual report
  • that no dividend is given
  • discharge from liability granted to board members and the Chief Executive Officer
  • that the board shall consist of six members without deputies
  • that remuneration should be paid to the Chairman of the Board of SEK 250,000 and an additional remuneration for the work as Chairman of the Board of SEK 400,000 and to other members of the company not employed by SEK 125,000 each. For members of the Remuneration Committee, a fee of forty thousand 40,000 is proposed to the Chairman and twenty thousand SEK 20,000 to each of the other members of the Committee
  • that the audit fee be paid according to approved invoice
  • re-election of Margareta Hagman, Eva Idén, Anthon Jahreskog, Kristina Sjöblom Nygren, Robert Molander and Peter Rothschild as board members
  • re-election of Peter Rothschild as Chairman of the Board
  • re-election of the registered accounting firm Deloitte AB
  • on the nomination committee in accordance with the nomination committee's proposal
  • guidelines for remuneration to senior executives in accordance with the Board's proposal, and
  • The Board’s proposal for a resolution regarding mandate for a new issuance of B shares 

About Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB (publ) is a pharmaceutical company with a product in Phase III with a vision to develop drugs influencing the infant microbiome, and thereby prevent or treat rare diseases affecting infants.

IBT is currently developing the drug candidate IBP-9414, for the prevention of necrotizing enterocolitis (“NEC”) and improvement of feeding tolerance in premature infants. IBP-9414 contains the active substance Lactobacillus reuteri, which is a human bacterial strain naturally present in breast milk. The product portfolio also includes another project, IBP-1016, for the treatment of gastroschisis, a severe and rare disease affecting infants. By developing these drugs, IBT has the potential to fulfill unmet needs for diseases where there are currently no prevention or treatment therapies available.

Infant Bacterial Therapeutics AB (“IBT”) is a public company domiciled in Stockholm. The company’s class B-shares shares are listed on Nasdaq Stockholm, Mid-cap (IBT B).

For additional information please contact
Staffan Strömberg, CEO
Daniel Mackey, CFO
Infant Bacterial Therapeutics AB
Bryggargatan 10
111 21 Stockholm
Phone: +46 70 670 1226
info@ibtherapeutics.com
www.ibtherapeutics.com

PublicationThe information was submitted for publication, through the agency of the contact persons set out above, at 16:30 CET on May 4, 2021. 

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

ACAMS’ ‘Virtual Europe’ Conference Offers Roadmap on Financial Crime Fight with Guidance from More than 80 Leading Compliance Experts11.5.2021 12:00:00 CEST | Press release

European regulators, senior industry executive and thought leaders to outline practical compliance steps for detecting and deterring financial crime, identifying the proceeds of corruption, fighting the illegal wildlife trade, tracing cryptocurrency transactions and deploying new technological tools LONDON, May 11, 2021 (GLOBE NEWSWIRE) -- As part of its ongoing effort to facilitate dialogue between private-sector compliance professionals and policy makers , ACAMS will host a three-day training and networking event for its Virtual Europe conference. Beginning May 18, attendees of this fully virtual gathering will learn about anti-financial crime (AFC) best practices and emerging financial-crime threats from senior supervisory officials and other subject-matter experts, including representatives from the European Commission, European Central Bank, MONEYVAL, the United Nations Office on Drugs and Crime, World Bank, the central bank of the Netherlands, Latvia’s Financial Intelligence Unit

Kommuniké från årsstämman i Acarix11.5.2021 11:50:00 CEST | Pressemelding

Kommuniké från årsstämman i Acarix Årsstämman 2021 i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 11 maj 2021 varvid aktieägarna fattade följande beslut. Med anledning av den pågående coronapandemin genomfördes stämman enbart genom poströstning, utan fysiskt deltagande. Fastställande av resultat- och balansräkningen Årsstämman beslutade att fastställa resultaträkningen och balansräkningen i Acarix samt koncernresultaträkningen och koncernbalansräkningen. Vinstdisposition Årsstämman beslutade att ingen utdelning skulle utgå till aktieägarna samt att tidigare balanserade medel, inklusive överkursfond samt årets resultat balanseras i ny räkning. Ansvarsfrihet Styrelsens ledamöter och den verkställande direktören beviljades ansvarsfrihet för verksamhetsåret 2020. Val av styrelse och revisor samt arvodering Årsstämman beslutade, i enlighet med valberedningens förslag, att styrelsen ska bestå av fyra ledamöter utan styrelsesuppleanter. Det beslutades vidare att Bolaget ska ha ett regi

Announcement from Acarix's annual general meeting11.5.2021 11:50:00 CEST | Press release

Announcement from Acarix's annual general meeting The annual general meeting 2021 ("AGM") of Acarix AB ("Acarix" or the "Company") was held today on 11 May 2021 and the following resolutions were passed by the meeting. Due to the ongoing corona pandemic, the AGM was carried out through postal voting only, without physical presence. Adoption of the income statement and the balance sheet The AGM resolved to adopt the income statement and the balance sheet in Acarix and the consolidated income statement and the consolidated balance sheet. Allocation of profit The AGM resolved not to pay any dividend to the shareholders and that the previously accrued profits, including the share premium account and year result would be carried forward. Discharge from liability The board of directors and the CEO were discharged from liability for the financial year 2020. Election of the board of directors, auditor and remuneration The AGM resolved, in accordance with the nomination committee's proposal tha

RESULT OF RIKSBANK REVERSED AUCTIONS KOMMUNINVEST BONDS11.5.2021 11:10:00 CEST | Press release

RESULT OF RIKSBANK REVERSED AUCTIONS KOMMUNINVEST BONDS Auction date2021-05-11Loan2206 Coupon0.25 %ISIN-codeSE0009269418Maturity2022-06-01 Tendered volume, SEK mln1,000 +/- 500 Volume offered, SEK mln4,850 Volume bought, SEK mln1,000 Number of bids7 Number of accepted bids3 Average yield-0.107 %Lowest accepted yield-0.114 %Highest yield-0.104 %% accepted at lowest yield 25.00 Auction date2021-05-11Loan2311 Coupon1.00 %ISIN-codeSE0010948240Maturity2023-11-13 Tendered volume, SEK mln1,000 +/- 500 Volume offered, SEK mln3,802 Volume bought, SEK mln1,000 Number of bids6 Number of accepted bids2 Average yield0.008 %Lowest accepted yield0.006 %Highest yield0.011 %% accepted at lowest yield 51.50 Auction date2021-05-11Loan2611Coupon1.00 %ISIN-codeSE0012569572Maturity2026-11-12 Tendered volume, SEK mln750 +/- 300 Volume offered, SEK mln3,450 Volume bought, SEK mln750 Number of bids7 Number of accepted bids1 Average yield0.428 %Lowest accepted yield0.428 %Highest yield0.428 %% accepted at lowes

Report from the Annual General Meeting of Auriant Mining AB (publ) held on 11 May 202111.5.2021 10:36:04 CEST | Press release

Auriant Mining AB (publ) held its Annual General Meeting on Tuesday, 11 May 2021. In order to mitigate the spread of Covid-19, the Annual General Meeting was conducted by advance voting only, on the basis of temporary statutory rules. The main resolutions passed at the meeting were as follows. More detailed information about the contents of the resolutions may be obtained from the complete notice of the AGM and the complete proposals. The notice and complete proposals are available on the company’s website: www.auriant.com. Adoption of balance sheets and profit and loss accounts It was resolved at the meeting to adopt the profit and loss account and balance sheet, as well as the consolidated profit and loss account and consolidated balance sheet for the financial year 2020. Allocation regarding the company’s result In accordance with the board’s and the managing director’s proposal, it was resolved at the meeting that the company’s non-restricted equity of SEK -86,488,459 is carried fo

Kommuniké från Auriant Mining AB (publ):s årsstämma den 11 maj 202111.5.2021 10:36:04 CEST | Pressemelding

Auriant Mining AB (publ) höll under tisdagen den 11 maj 2021 sin årsstämma. För att motverka spridning av Covid-19 genomfördes årsstämman enbart genom förhandsröstning med stöd av tillfälliga lagregler . Följande huvudsakliga beslut fattades vid årsstämman. För mer detaljerad information om innehållet i besluten hänvisas till den fullständiga kallelsen till årsstämman och de fullständiga förslagen. Kallelse till årsstämman samt fullständiga förslag finns tillgängliga på bolagets hemsida, www.auriant.se. Fastställande av balans- och resultaträkningar Stämman beslutade att fastställa resultaträkningen och balansräkningen samt koncernresultat-räkningen och koncernbalansräkningen för räkenskapsåret 2020. Disposition av bolagets resultat Stämman beslutade, i enlighet med styrelsens och verkställande direktörens förslag, att bolagets fria egna kapital om -86 488 459 kronor balanseras i ny räkning och att ingen utdelning lämnas för räkenskapsåret. Ansvarsfrihet Stämman beviljade styrelseledam

Klövern - Meddelande om skriftligt förfarande11.5.2021 10:20:30 CEST | Pressemelding

Klövern AB (publ) (”Klövern”) har idag instruerat Nordic Trustee & Agency AB (publ) (”Agenten”), som agerar agent under Klöverns seniora säkerställda obligation som emitterades i oktober 2019 med ett belopp om 50 000 000 USD med ISIN NO0010866205 (”Obligationslånet”), att inleda ett skriftligt förfarande där Klövern ber om att obligationsinvesterarna röstar för att ändra vissa bestämmelser i villkoren för Obligationslånet. Klövern önskar ändra villkoren för Obligationslånet och emittera ytterligare 50 000 000 USD till ett fåtal investerare samt förlänga den tidigare löptiden som löper till den 15 oktober 2021 till att löpa till den 15 juli 2023. I samband med detta kommer bland annat lämnade säkerheter att utökas. Ett meddelande om skriftligt förfarande kommer att skickas till samtliga obligationsinnehavare den 11 maj 2021 i enlighet med villkoren för Obligationslånet. Det skriftliga förfarandet avslutas senast den 31 maj 2021. Kallelsen gällande skriftligt förfarande finns på Klöverns